enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. DrugBank - Wikipedia

    en.wikipedia.org/wiki/DrugBank

    The first version of DrugBank was released in 2006. [1] This early release contained relatively modest information about 841 FDA-approved small molecule drugs and 113 biotech drugs. It also included information on 2133 drug targets. The second version of DrugBank was released in 2009. [2]

  3. Template:Cite DrugBank - Wikipedia

    en.wikipedia.org/wiki/Template:Cite_DrugBank

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file

  4. File:Drugbank logo.svg - Wikipedia

    en.wikipedia.org/wiki/File:Drugbank_logo.svg

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us

  5. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  6. Brensocatib - Wikipedia

    en.wikipedia.org/wiki/Brensocatib

    This pharmacology -related article is a stub. You can help Wikipedia by expanding it.

  7. Clovibactin - Wikipedia

    en.wikipedia.org/wiki/Clovibactin

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file

  8. Tiabendazole - Wikipedia

    en.wikipedia.org/wiki/Tiabendazole

    Tiabendazole is also used as a food additive, [2] [3] a preservative with E number E233 (INS number 233). For example, it is applied to bananas to ensure freshness, and is a common ingredient in the waxes applied to the skins of citrus fruits. It is not approved as a food additive in the EU, [4] Australia and New Zealand. [5]

  9. Tucatinib - Wikipedia

    en.wikipedia.org/wiki/Tucatinib

    Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable or metastatic HER2-positive breast cancer, including those with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.